LMP2-Specific IL12-secreting TCR-T Cells
/ TCRCure
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 12, 2020
LMP2-Specific IL12-secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma
(clinicaltrials.gov)
- P1/2; N=20; Not yet recruiting; Sponsor: Xinqiao Hospital of Chongqing
New P1/2 trial • Head and Neck Cancer • Nasopharyngeal Carcinoma • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1